series-c-plus
Stage
2
Investors
About
Endogenex develops an investigational pulsed electric field (PEF) medical device, the pulsENDO system, designed to reset metabolic signaling in the small intestine to improve blood glucose control in people with type 2 diabetes.
Explore Endogenex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.